Treatment of hereditary hemorrhagic telangiectasias with sclerotherapy: A case series

Jenny Ji, Andrew M. Peterson, Jay F. Piccirillo

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Hereditary hemorrhagic telangiectasia (HHT) is characterized by abnormal blood vessel formation. One treatment for HHT-related arteriovenous malformations (AVMs) is sclerotherapy, which collapses the blood vessels by irritating the endothelial lining. Methods: This case series describes two HHT patients undergoing in-office sodium tetradecyl sulfate sclerotherapy for non-nasal telangiectasias and AVMs. The first patient had AVMs on the red lip while the second patient had an AVM and several telangiectasias on the tongue. Results: Both patients' AVMs required only one treatment visit and were no longer noticeable within a week. Neither of the patients had any side effects from treatment. Conclusion: Sclerotherapy was used to successfully treat HHT-related AVMs in-office with no scarring and is an option that should be considered by providers.

Original languageEnglish
Article number104537
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume46
Issue number1
DOIs
StatePublished - Jan 1 2025

Keywords

  • Hereditary hemorrhagic telangiectasia
  • Lip
  • Sclerotherapy
  • Tongue

Fingerprint

Dive into the research topics of 'Treatment of hereditary hemorrhagic telangiectasias with sclerotherapy: A case series'. Together they form a unique fingerprint.

Cite this